Nastavni materijal
1. Treatment of Hypertension in Adults With Diabetes
American Diabetes Association Diabetes Care 2010;33 (suppl1)
2. Grossman E, Messerli FH. Hypertension and diabetes Adv Cardiol 2008;45:82-106.
3.Wild S, Roglic G, Green A, Sicre R, King H. Global prevalence of diabetes: estimates for
the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047–1053.
4.Kearney PM, Whelton M, Reynolds K, Mountner P, Whelton PK, He J. Global burden of
hypertension: analysis of worldwide data. Lancet 2005; 365: 217-223.
5.Stas NS, Fadi A. El-Atat AF, Sowers JR. Pathogenesis of Hypertension in Diabetes
Rev Endo & Metab Dis 2004;5:221–225
6.Low Wang C, Goalstone ML, Draznin B. Molecular mechanisms of Insulin resistance that
impact cardiovascular biology. Diabetes 2004; 53(11):2735-2740.
7.Chavanu K, Merkel J, Quan AM. Role of ambulatory blood pressure monitoring in the
management of hypertension. Am J Health Syst Pharm 2008;65:3:209-218.
8.Stults B,Jones RE. Management of Hypertension in Diabetes
Diabetes Spectr. 2006;19:25-31.
9. Whalen KL, Stewart RD Pharmacologic management of hypertension in patients with
diabetes. Fam Physician. 2008;78(11):1277-1282
10. Bakris GL,Sowers JR on behalf of the American Society of Hypertension Writing Group
Treatment of hypertension in patients with diabetes—an update J Am Soc Hypertension
2009;3:150-155
Dopunska literatura za seminare i završnu raspravu: (podložna nadopuni ovisno o željama
polaznika)
1.Reaven GM. Insulin resistance and its consequences. In diabetes Mellitus:
A fundamental and clinical text. 3rd ed. LeRoith D, Taylor SI, Olefasky JM, Eds.
Philadelphia, Lippincott, Williams and Wilkins, 2004, p.899-915.
2.Vinik AI, Dan Ziegler D. Diabetic Cardiovascular Autonomic Neuropathy. Circulation.
2007;115:387-396.
3.Duvnjak L, Vučković S, Car N, Metelko Ž. Relationship between autonomic function, 24-h
blood pressure and albuminuria in normotensive, normoalbuminuric patients with type 1
diabetes.
J Diab Complic 2001; 15(6):314-319.
4.Duvnjak L, Vučković S, Pepeonik Ž, Metelko Ž
Relationship between autonomic neuropathy, 24h blood pressure and retinopathy in
normoalbuminuric and normotensive type 1 diabetic patients Diab Nutr Metab. 2003;
16(2):102-108.
5.Blood pressure lowering treatment trialists collaboration. Effects of different blood pressure
lowering regimens on major cardiovascular events in individuals with and without diabetes
mellitus. Results of prospectively designed overviews of randomised controlled trials. Arch
Intren Med 2005; 165:1410-1419.
6.The Heart Outcomes Prevention Study Investigators. Effects ramipril on cardiovascular and
microvascular outcomes in people with diabetes mellitus; results of the HOPE study and
MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation (HOPE) Investigators.
Lancet 2000; 355: 253-259.
7.Ruggenenti P,Fassi A, Ilieva AP.Bergamo Nephrologic Dabetes Complications Trial
Investigators (BENEDICT). Preventing microalbuminuria in type 2 diabetes. N Engl J Med
2004; 351: 1941-1951
8.Bakris GL, Weir MR, Secic M, Campbell B, Wriss-McNulty A. Different effects of calcium
antagonists on markers of nephropathy progession. Kidney Int 2004:65:1991-2002.
9.Kveiborg B, Christiansen B, Major-Petersen A, Torp-Pedersen C. Metabolic effects of betaadrenoceptor antagonists with special emphasis on carvedilol. Am J Cardiovasc Drugs.
2006;6(4):209-217.
ISPIT ĆE SE ODRŽATI
17.11.2010 u 16h u Spomen knjižnici Sveučilišne klinike Vuk Vrhovac